Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$12.41 USD
+0.01 (0.08%)
Updated Aug 6, 2024 03:59 PM ET
After-Market: $12.42 +0.01 (0.08%) 6:42 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLBT 12.41 +0.01(0.08%)
Will CLBT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLBT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLBT
Is Allot (ALLT) Outperforming Other Business Services Stocks This Year?
Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?
CLBT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates
Arbe Robotics Ltd. (ARBE) Reports Q1 Loss, Lags Revenue Estimates
Other News for CLBT
Cellebrite Appoints Renowned Cybersecurity Expert Sigalit Shavit as Chief Information Officer
Cellebrite appoints Shavit as CIO
Relativity and Cellebrite Partner to Unleash the Power of Mobile Data
Vertical Market Software Trends And Constellation's Mega Deals
Will The Nasdaq 100's Relief Rally Hold Or Is A Sharp Decline Inevitable?